WO2005017131A3 - Methods for the differentiation of human stem cells - Google Patents
Methods for the differentiation of human stem cells Download PDFInfo
- Publication number
- WO2005017131A3 WO2005017131A3 PCT/US2004/026486 US2004026486W WO2005017131A3 WO 2005017131 A3 WO2005017131 A3 WO 2005017131A3 US 2004026486 W US2004026486 W US 2004026486W WO 2005017131 A3 WO2005017131 A3 WO 2005017131A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- stem cells
- cells
- differentiation
- human stem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Abstract
Methods for differentiating human embryonic stem cells into specific cell types are disclosed herein. These methods can be used to generate synaptically active dopaminergic neurons. In one embodiment, the differentiated cells are neuronal cells that can be used in the treatment of neurodegenerative disorders such as Parkinson's disease. Methods are also disclosed herein for differentiating human embryonic stem cells into cells of the endoderm, mesoderm, and ectoderm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49534603P | 2003-08-14 | 2003-08-14 | |
US60/495,346 | 2003-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005017131A2 WO2005017131A2 (en) | 2005-02-24 |
WO2005017131A3 true WO2005017131A3 (en) | 2005-11-24 |
Family
ID=34193305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/026486 WO2005017131A2 (en) | 2003-08-14 | 2004-08-13 | Methods for the differentiation of human stem cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005017131A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132226B2 (en) | 2008-11-14 | 2015-09-15 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
JP7315923B2 (en) | 2017-09-29 | 2023-07-27 | 史敏 石野 | Organ organoid and method for producing the same |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
EP1709159B1 (en) | 2003-12-23 | 2019-05-15 | Viacyte, Inc. | Definitive endoderm |
US8586357B2 (en) | 2003-12-23 | 2013-11-19 | Viacyte, Inc. | Markers of definitive endoderm |
US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
MX2007001772A (en) | 2004-08-13 | 2007-07-11 | Univ Georgia Res Found | Compositions and methods for self-renewal and differentiation in human embryonic stem cells. |
FI20055398A0 (en) | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Method for evaluating cell populations |
ES2687233T3 (en) | 2005-10-27 | 2018-10-24 | Viacyte, Inc. | Endoderm of the dorsal and ventral proximal intestine expressing PDX-1 |
SG10201405380QA (en) | 2006-03-02 | 2014-10-30 | Cythera Inc | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
CN102559587A (en) * | 2010-12-16 | 2012-07-11 | 中国科学院上海药物研究所 | Preparing method of iPS cell and medium for preparing iPS cell |
JP6476127B2 (en) * | 2012-11-29 | 2019-02-27 | タカラ バイオ ヨーロッパ アーベー | Maturation of human pluripotent stem cell-derived hepatocyte-like cells |
EP3071685A4 (en) * | 2013-11-21 | 2017-07-05 | Memorial Sloan Kettering Cancer Center | Specification of functional cranial placode derivatives from human pluripotent stem cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001083715A2 (en) * | 2000-05-01 | 2001-11-08 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary, | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
-
2004
- 2004-08-13 WO PCT/US2004/026486 patent/WO2005017131A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001083715A2 (en) * | 2000-05-01 | 2001-11-08 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary, | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
Non-Patent Citations (4)
Title |
---|
CARPENTER M K ET AL: "Enrichment of neurons and neural precursors from human embryonic stem cells", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 172, no. 2, December 2001 (2001-12-01), pages 383 - 397, XP002313092, ISSN: 0014-4886 * |
SCHULDINER MAYA ET AL: "Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 97, no. 21, 10 October 2000 (2000-10-10), pages 11307 - 11312, XP002184277, ISSN: 0027-8424 * |
STUDER L: "Stem cells with brainpower.", NATURE BIOTECHNOLOGY. DEC 2001, vol. 19, no. 12, December 2001 (2001-12-01), pages 1117 - 1118, XP002327040, ISSN: 1087-0156 * |
WALSH JAMES ET AL: "Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cells.", APMIS, vol. 111, no. 1, January 2003 (2003-01-01), pages 197 - 211, XP002340476, ISSN: 0903-4641 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132226B2 (en) | 2008-11-14 | 2015-09-15 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
JP7315923B2 (en) | 2017-09-29 | 2023-07-27 | 史敏 石野 | Organ organoid and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
WO2005017131A2 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005017131A3 (en) | Methods for the differentiation of human stem cells | |
IL173889A0 (en) | In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders | |
WO2006044204A3 (en) | Neuronal progenitors from feeder-free human embryonic stem cell culture | |
GB2393733B (en) | Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease | |
WO2001011011A3 (en) | Multipotent adult stem cells and methods for isolation | |
IL173832A0 (en) | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells | |
WO2008157791A3 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
GB2407821A (en) | Generation of neural stem cells from undifferentiated human embryonic stem cells | |
EP1491093A3 (en) | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
EP4269561A3 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
WO2005030240A3 (en) | Vege-cor vege-d materials and methods for stimulation of neural stem cells | |
WO2000050568A3 (en) | Transplantation of haematopoietic cells | |
WO2004087870A3 (en) | Neuronal cell lineages and methods of production thereof | |
ZA200602498B (en) | In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders | |
WO2009018587A3 (en) | Derivation of neural stem cells from embryonic stem cells and methods of use thereof | |
WO1999045103A3 (en) | Human spinal cord cell lines and methods of use therefor | |
WO2004042018A3 (en) | Dopamine neurons from human embryonic stem cells | |
WO2006110806A3 (en) | Multipotent adult stem cells | |
ES2180433A1 (en) | Use of haematopoietic stem cells in the generation of neural stem cells | |
WO2003040304A3 (en) | Method of proliferation in neurogenic regions | |
WO2005021716A3 (en) | Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders | |
WO2003057853A3 (en) | Oxidative stress-resistant cell lines and methods of use thereof | |
DE60133563D1 (en) | cules | |
WO2001017547A3 (en) | Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons | |
EP2071021A3 (en) | Bone marrow-derived neuronal cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |